Iovance Biotherapeutics
IOVA
$11.02
Share price
-18.03%
Change (1 day)
49.80%
Change (1 year)
Categories
EPS for Iovance Biotherapeutics (IOVA)
EPS in 2023 (TTM): -$2.24
According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is -$2.24. In 2022 the company made an earnings per share (EPS) of -$2.48 a decrease over its 2021 EPS that were of -$2.22.
EPS history for Iovance Biotherapeutics from 2008 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.24 | -9.68% |
| 2022 | -$2.48 | 11.71% |
| 2021 | -$2.22 | 17.46% |
| 2020 | -$1.89 | 19.62% |
| 2019 | -$1.58 | 23.44% |
| 2018 | -$1.28 | -9.22% |
| 2017 | -$1.41 | -20.34% |
| 2016 | -$1.77 | 176.56% |
| 2015 | -$0.64 | 30.61% |
| 2014 | -$0.49 | -93.12% |
| 2013 | -$7.13 | 71.81% |
| 2012 | -$4.15 | -87.8% |
| 2011 | -$34.00 | 1593.63% |
| 2010 | -$2.01 | 61423.81% |
| 2009 | -$0.003263 | -99.67% |
| 2008 | -$1.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -97.32% | Bahamas |
 NRC Health
NRC | $1.19 | -153.13% | 🇺🇸 USA |